Clinical Trials
ABACUS-2
A phase II, randomised, controlled, double masked, multiple dose study of the safety, tolerability and efficacy of intravitreal KIO-301 in patients with late-stage retinitis pigmentosa
Overview
A phase II, randomised, controlled, double masked, multiple dose study of the safety, tolerability and efficacy of intravitreal KIO-301 in patients with late-stage retinitis pigmentosa
- Principal Investigator
Dr Doron Hickey
A phase II, randomised, controlled, double masked, multiple dose study of the safety, tolerability and efficacy of intravitreal KIO-301 in patients with late-stage retinitis pigmentosa
- Principal Investigator
Learn more
View this study on ClinicalTrials.gov
See the ClinicalTrials.gov database listing for more detailed information about this study.